Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved save search
mCloud Special Committee Approves New Corporate Structure to Maximize Value from Exploration of Strategic Alternatives
Published: 2023-08-22 (Crawled : 04:00) - prnewswire.com
MCLD | $0.111 -18.02% 1.1M
|
n/a
|
| O: -2.83%
H: 9.09%
C: 4.0%
Viveve Announces FDA Approval to Conduct PURSUIT Trial for Improvement of Stress Urinary Incontinence
Published: 2020-07-07 (Crawled : 19:10) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
| Email alert
Add to watchlist
fda approval fda trial approval
Greenrose Acquisition Corp. Stockholders Approve Business Combination
Published: 2021-10-27 (Crawled : 23:00) - globenewswire.com
GNRS 4 | $0.001 33900.0% 110K
|
Finance
|
| O: 2.97%
H: 0.96%
C: -2.4%
acquisition acquisition corp approval
Empower Clinics Kai Medical Laboratory Becomes Approved Vaccine Provider
Published: 2021-11-08 (Crawled : 23:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250
|
Health Services
|
| O: -0.33%
H: 0.73%
C: -2.17%
vaccine approval
Empower Clinics subsidiary Kai Medical approved to administer COVID-10 Vaccines in the United States
Published: 2021-10-25 (Crawled : 22:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250
|
Health Services
|
| O: 2.41%
H: 0.0%
C: -3.45%
covid vaccine
Empower Clinics Kai Medical Laboratory Approved to Administer Covid-19 Vaccines in the U.S.
Published: 2021-10-25 (Crawled : 22:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250
|
Health Services
|
| O: 2.41%
H: 0.0%
C: -3.45%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.32%
H: 0.36%
C: 0.22%
covid vaccine covid-19
Tailwind Acquisition Corp. and NUBURU, Inc. Announce Stockholder Approval of Business Combination – Marketscreener.com
Published: 2022-12-27 (Crawled : 15:00) - spacfeed.com
KKR | $93.35 -1.35% -0.38% 4.6M
|
Finance
|
| O: -0.77%
H: 0.19%
C: -1.33%
acquisition approval
Tauriga Sciences Inc. Approved to Renew its Status as a Vendor to the National Association of College Stores
Published: 2021-12-01 (Crawled : 17:00) - globenewswire.com
TAUG | $0.0001
|
|
| O: -15.8%
H: 30.64%
C: 21.14%
store
COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Report 2021: Analysis by Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Clinical Trials
Published: 2022-02-11 (Crawled : 21:00) - prnewswire.com
GWHP | $0.0001 4000.0% 86K
|
Mining, Quarrying, and Oil and ...
| Email alert
Add to watchlist
PMCB | $2.215 4.48% 4.29% 5.9K
|
Manufacturing
| Email alert
Add to watchlist
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
| Email alert
Add to watchlist
covid-19 als ces trials device trial approval covid clinical trials report test
LMP Automotive Holdings, Inc. Receives General Motors’ Manufacturer Approval for Certain of its Subsidiaries as it Relates to its Stage 1 Southeast Acquisitions
Published: 2020-12-23 (Crawled : 21:02) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: -0.63%
H: 0.7%
C: -7.72%
acquisition acquisitions approval
LMP Automotive Holdings, Inc. Announces Board Approval for Debt Refinancing and Conditional Approval of a Stock Buy Back and Dividend
Published: 2021-07-08 (Crawled : 21:00) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: 14.98%
H: 0.0%
C: 0.0%
approval
LMP Automotive Holdings, Inc. Announces its Board of Directors Approved an Immediate Pursuit of Strategic Alternatives Including a Sale of the Company
Published: 2022-02-16 (Crawled : 12:30) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: 5.11%
H: 1.72%
C: -24.89%
ces automotive media alternative
Technicolor Creative Studios: availability of a prospectus approved by the French Autorité des marchés financiers under number 23-139
Published: 2023-05-02 (Crawled : 19:00) - globenewswire.com
TCLRY | $0.001 1000.0% 140K
|
Manufacturing
|
| O: 36.36%
H: 0.0%
C: -26.67%
approved
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
Published: 2022-01-19 (Crawled : 10:00) - biospace.com/
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: 1.51%
H: 3.09%
C: -1.37%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -6.53%
H: 3.29%
C: 3.29%
covid-19 aviptadil expansion program respiratory covid report collaboration
Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
Published: 2022-01-06 (Crawled : 10:00) - biospace.com/
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: 19.47%
H: 3.85%
C: -11.85%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 2.87%
H: 0.0%
C: 0.0%
NRXP 1 d | $3.025 -27.63% -38.18% 760K
|
Manufacturing
|
| O: -3.39%
H: 6.19%
C: 3.92%
covid-19 treatment fda aviptadil risk covid media submission
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: -20.21%
H: 40.17%
C: 33.19%
trial approval therapeutics initiated
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Published: 2022-07-13 (Crawled : 07:00) - biospace.com/
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: -14.17%
H: 21.5%
C: 15.26%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -1.41%
H: 0.0%
C: 0.0%
treatment drug acquire approved agreement
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Published: 2023-01-17 (Crawled : 11:00) - biospace.com/
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: -8.26%
H: 14.0%
C: 10.0%
td011 treatment t-cell trial approval therapeutics
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
Published: 2022-12-27 (Crawled : 14:00) - globenewswire.com
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: 3.33%
H: 12.26%
C: 8.06%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 2.37%
H: 0.0%
C: 0.0%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -3.23%
H: 0.28%
C: -31.11%
urea fda approval therapeutics
Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory
Published: 2023-05-15 (Crawled : 10:00) - biospace.com/
RLFTY | $1.4006 733.33% 100
|
n/a
| Email alert
Add to watchlist
RLFTF | $1.4 11.45% 1.3K
|
n/a
| Email alert
Add to watchlist
approval therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.